Business Wire

Toshiba Launches New ELERA™ Security Suite to Address the Industry’s Challenges Around Shrink

12.9.2023 16:05:00 EEST | Business Wire | Press release

Share

The new ELERA Security Suite from Toshiba Global Commerce Solutions empowers retailers to minimize shrink while providing consumers with enhanced checkout experiences and reduced friction. According to the latest data from the National Retail Federation, retail shrink accounted for $94.5 billion in losses in 2021 in the U.S. and continues to be a critical challenge for retailers. Available later this year, the ELERA™ Security Suite offers retailers a comprehensive solution to protect their bottom line and combat multiple forms of shrink.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230912900113/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

The A.I.-powered ELERA™ Security Suite offers retailers a comprehensive solution to minimize shrink while providing consumers with enhanced checkout experiences. (Photo: Business Wire)

“In a world where every second and every cent counts, ELERA™ Security Suite is not just a tool but a strategy—turning data into decisions and losses into profits,” said Yevgeni Tsirulnik, SVP of Innovation and Incubation at Toshiba Global Commerce Solutions. “As global leaders in retail solutions, our Toshiba team and partners came together to envision and develop the A.I.-powered ELERA Security Suite to enhance their loss prevention measures that have a direct and positive impact on retailer profits while also improving the shopper experience.”

The ELERA Security Suite end-to-end solution deployed as-a-service through Toshiba’s IoT platform, fully orchestrates computer vision cameras with advanced edge A.I., to enhance profit protections and shopper experiences through:

  • Monitoring consumer behavior in real-time – without servers or processing lag – via TCx® EDGEcam+ and multiple sensors, which adds enhanced security throughout the checkout area
  • Responding to incidents as they occur for more impactful and timely resolutions with leading A.I.-powered computer vision
  • Notifying shoppers of potential errors through proactive alerts and allowing them to correct the issue themselves – minimizing employee intervention and improving the checkout experience
  • Differentiating customer’s items vs. store items they’re purchasing, improving recognition accuracy, and reducing incorrect warnings

The modular ELERA Security Suite system empowers retailers with versatility and opportunities to leverage the latest technology to meet their business needs. The ELERA Security Suite can be part of the overall ELERA™ solution, or it can be attached to other Toshiba or third-party POS systems.

“We are excited to expand our collaboration with Toshiba Global Commerce Solutions by integrating the Qualcomm® QRB5165 System-on-Chip (SoC) for IoT into Toshiba’s TCx EDGEcam+ to provide one of the best A.I. edge processing platforms in the market,” stated Art Miller, Vice President, Business Development and Head of Retail and Payments, Qualcomm Technologies, Inc. “Qualcomm QRB5165 SoC brings distributed A.I. and compute capabilities to the edge eliminating the need for expensive and power-intensive servers in the back of the store.”

This A.I.-driven solution presents benefits to both retailers and consumers across multiple touchpoints. ELERA™ Security Suite expands on the previously available ELERA™ Produce Recognition that leverages A.I. and computer vision to accurately and efficiently identify produce and eliminate the need to input produce codes at checkout manually. Retailers are already benefiting from the produce recognition innovation through improved inventory accuracy and throughput in the self-service experience enabling a more seamless checkout and positive consumer experience. Based on recent retailer data, Toshiba has found that shoppers save as much as five seconds per produce item lookup during checkout.

Retailers that invest in the ELERA Security Suite can see strong returns on their investment in this new technology suite through increased inventory accuracy, decreased store staff intervention, and increased adoption of their self-checkout lanes. Given Toshiba’s focus on retailers and consumer privacy, we also offer peace of mind by meeting the requirements of applicable data privacy laws, including all federal, state, regional, territorial, national, and local laws, regulations, and rules by any government agency or authority that relate to the processing or the security of personal data.

Toshiba experts will be at GroceryShop 2023 in Las Vegas from September 19-21 to showcase the ELERA Security Suite and a portfolio of other retail solutions that enable retailers to re-imagine, accelerate, and differentiate their shopping experiences (booth #1050).

About Toshiba Global Commerce Solutions

Toshiba Global Commerce Solutions empowers retail to thrive and prosper through a dynamic ecosystem of smarter, more agile solutions and services that enable retailers to resiliently evolve with generations of consumers and adapt to market conditions. Supported by a global organization of devoted employees and partners, retailers gain more visibility and control over operations while enjoying the flexibility to build, scale, and transform retail experiences that anticipate and fulfill consumers’ ever-changing needs. Visit commerce.toshiba.com and engage with us on X, formerly known as Twitter, Facebook, LinkedIn, Instagram, and YouTube, to learn more.

Toshiba Global Commerce Solutions is a wholly owned subsidiary of Toshiba Tec Corporation, which is traded on the Tokyo Stock Exchange.

Qualcomm

Qualcomm is a trademark or registered trademark of Qualcomm incorporated. Qualcomm branded products are products of Qualcomm Technologies, Inc. and/or its subsidiaries. Qualcomm patented technologies are licensed by Qualcomm Incorporated.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Toshiba Global Commerce Solutions
Elizabeth Romero
Director, Corporate Communications
elizabeth.romero@toshibagcs.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SWISSto12 and Mitsubishi Electric Corporation Announce Strategic Partnership14.9.2026 10:00:00 EEST | Press release

SWISSto12 today announced a memorandum of understanding (MoU) with Mitsubishi Electric Corporation (MELCO) (TOKYO: 6503) to pursue joint opportunities on advanced payloads, radio frequency (RF) products, and market development in Japan and the APAC region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260914982179/en/ Masahiko Arai, Executive Officer and Group President, Defense & Space Systems, Mitsubishi Electric, and Dr. Emile de Rijk, Chief Executive Officer, SWISSto12 Joint opportunities will leverage MELCO’s extensive satellite system expertise and integration capabilities together with SWISSto12’s proprietary 3D-printing designs and processes that form the foundation of its next-generation payloads—smaller, lighter, highly performant, yet built in materially shorter timeframes. The MoU underscores growing market adoption of SWISSto12’s HummingLink payload technology that leverages 3D-printing, with more than 2,000 pr

U.S. FDA Accepts New Drug Application Under Priority Review for Takeda’s Zasocitinib in Moderate-to-Severe Plaque Psoriasis, with Potential to Redefine Oral Treatment Expectations14.9.2026 10:00:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) under Priority Review for zasocitinib (TAK-279) for the treatment of adults with moderate-to-severe plaque psoriasis. Zasocitinib is an investigational, next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2) inhibitor, which demonstrated rapid, durable and consistent skin clearance in Phase 3 plaque psoriasis studies.1-3 Addressing unmet needs in psoriasis treatment “Despite progress in psoriasis care, there remains a need for highly effective oral therapies that also address the diverse and often challenging manifestations of psoriasis, including involvement of high-impact sites like the scalp,” said Andy Plump, M.D., Ph.D., president of R&D at Takeda. “Our Phase 3 data demonstrated rapid and durable skin clearance across various patient types and in high-impact and hard-to-treat areas. Based on the results across nearly 3,000 patients, zaso

Thales Builds Cryptographic Security for the Age of AI and Post-Quantum Computing14.9.2026 10:00:00 EEST | Press release

According to the 2026 Thales Data Threat Report, the threat of Harvest Now, Decrypt Later (HNDL) attacks was the top-cited risk, with 59% of organizations reporting that they are prototyping and evaluating post-quantum cryptography (PQC) algorithms to prepare for the quantum era. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260804748922/en/ ©Thales To help organizations turn this readiness into deployment,Thales, a global leader in advanced technologies, today announced the launch of Luna 8, its next-generation hardware security module. Designed for the transition to post-quantum cryptography, Luna 8 enables organizations to securely store, protect, and manage cryptographic keys with market-leading performance, scalability, and speed. As organizations face growing pressure from emerging quantum threats, expanding AI workloads and evolving stringent regulatory requirements, Luna 8 provides the performance, security and cryp

Focused Support Launches Cavok STRIKE to Expand Link-16 Participation Across the Joint Force14.9.2026 08:00:00 EEST | Press release

Focused Support LLC today announced the launch of Cavok STRIKE, an integrated software capability that expands the Link-16 tactical battlespace picture by enabling additional operational platforms to participate in the Link-16 network. Modern battlefields have increasing numbers of unmanned systems, sensors, and supporting platforms operating throughout the joint battlespace. The rapid proliferation of Group 1, 2, and 3 UAS, including both expendable and recoverable systems, has created a growing need to integrate these assets into the broader tactical network. Many of these platforms provide operationally relevant information but have historically remained outside the Link-16 network due to limitations in size, weight, power, platform integration complexity, or acquisition cost. Cavok STRIKE addresses this gap by enabling platforms to participate in the Link-16 network as non-command-and-control participants. This allows those platforms to interoperate with traditional Link-16 platfor

Fujirebio Expands Access to Blood-based Neurology Testing in Brazil with ANVISA Market Authorization for Lumipulse® G NfL Blood and Lumipulse G pTau 217 Plasma14.9.2026 08:00:00 EEST | Press release

H.U. Group Holdings Inc. and its wholly owned subsidiary Fujirebio today announced that the Brazilian Health Regulatory Agency (ANVISA) has granted market authorization for the Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma assays for use on the fully automated LUMIPULSE® G immunoassay platform in Brazil. “ANVISA authorization of the Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma assays marks another important step in our mission to expand access to reliable, clinically meaningful blood-based biomarkers for clinicians and patients worldwide,” said Christiaan De Wilde, CEO of Fujirebio Europe N.V. “By making both neurological biomarker assays available to laboratories on a single, fully automated platform, we are helping support more informed clinical decision-making across a broad range of neurological conditions and throughout the diagnostic pathway.” The Brazilian ANVISA authorizations are based on the already CE marked in vitro diagnostics (IVD) approvals of these two

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye